Liu et al. indicated that caveolin-1 inhibits autophagy of cancer cells in hepatocellular carcinoma, providing potential target for autophagy inhibition as a novel treatment (Liu et al., 2016). This evidence concerns the gene CAV1 and hepatocellular carcinoma.